Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Friday, July 10, 2026
🇪🇺 EMA

trastuzumab deruxtecan News

🇪🇺 EMA ← All news

EMA trastuzumab deruxtecan coverage for business development, investment, and market access teams

High impact AnalysisMay 1, 2026

Antibody-Drug Conjugates in Breast Cancer: Enhertu vs. Trodelvy in EU Market

EMA · oncology · 10 min

Dr. Natalie Hughes
High impact AnalysisApr 27, 2026

EU Market Access ADCs: NICE, G-BA & HAS Assessments of Trastuzumab Deruxtecan

EMA · oncology · 9 min

Dr. Lukas Schneider

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.